Medical devices can interact with tissue of a subject to diagnose or treat the subject. For example, the subject can have neurological pathologies, which need to be diagnosed and treated.
Neural recording and neurostimulation devices can be used in the cochlea, the retina, the peripheral nervous system, the spine, the brain, and other parts of the body. Generally, neural recording can be performed in deep brain structures by surgically inserting conductive electrodes and amplifying neurological signals using external electronic equipment. Neurostimulation can be performed by surgically implanting conductive electrodes in the target, and using an implantable pulse generator to apply electrical signals to the conductive electrodes.
The conductive electrodes can be inserted into the deep brain structures through stereotaxy or endoscopy procedures. During these procedures a lead cannula can be implanted near the target tissue. The conductive electrodes can be fed through the cannula to the target tissue.
Described herein are microelectrode devices to provide highly localized neural recording or neural stimulation to a neurological target. The device includes a plurality of electrodes disposed along the shafts of deployable flexible pins. The deployable flexible pins are enclosed within an elongated probe shaft, and can be expanded from their enclosure. Additionally, a specifically manufactured protective housing can be coupled to at least a portion of the elongated probe shaft. During deployment of the flexible pins, the protective housing of the microelectrode device reduces friction between the flexible pins and the probe shaft and thus reduces the risk of delamination to the flexible pins during deployment.
According to one aspect of the disclosure, an implantable microelectrode device includes an elongated shaft having an outer wall and a distal end. The elongated shaft defines an internal lumen therethough and the outer wall defines a plurality of windows therein. An end cap is coupled with the distal end of the elongated shaft. The end cap has a frustum end projecting into the internal lumen of the elongated shaft. The device also includes a protective tube coupled with the outer surface of the elongated shaft. A portion of the protective tube covers a portion of each of the plurality of windows. The device also includes a probe assembly. The probe assembly includes a plurality of flexible pins. Each of the plurality of flexible pins can be deployed through a different one of the plurality of windows. Each of the plurality of flexible pins exit the elongated shaft at an angle defined by the frustum end of the end cap and a distal end of the protective tube.
In some implementations, the protective tube is configured to substantially reduce a friction induced on the plurality of flexible pins during deployment through the plurality of windows. Compared to a device without the protective tube, the protective tube may reduce the friction induced on the plurality of flexible pins during deployment by between about 50% and about 20%. The protective tube can include a polymeric material. In some implementations, the protective tube and the plurality of flexible pins include a same substrate material. The plurality of flexible pins can be configured to slide along the frustum end of the end cap projecting into the internal lumen and the protective tube. The coefficient of friction between the protective tube and the plurality of flexible pins may be between about 0.5 and about 0.01 or between about 0.2 and about 0.01.
In some implementations, the microelectrode device can also include a microelectromechanical system (MEMS) component that can include a first plurality of MEMS legs. Each of the first plurality of MEMS legs can be aligned and coupled with an outer face of one of the plurality of flexible pins. The device can also include a second plurality of MEMS legs that can be coupled to the first plurality of MEMS legs by a foldable strip. Each of the second plurality of MEMS legs can be aligned and coupled with an inner face of one of the plurality of flexible pins. The MEMS leas can include at least one electrode.
In some implementations, at least one electrode is disposed on each of the plurality of flexible pins. The probe assembly can further include a central pin that is deployed through a central channel of the end cap. The frustum end of the end cap can define the minimum exit angle of the flexible pins from the elongated shaft. The protective tube can define the maximum exit angle of the flexible pins from the elongated shaft. In some implementations, the device includes at least four windows.
The device can include a translation system. The translation system can include a translation ring and a translator rod. The translation system can be configured to convert a rotational movement of the translation ring into an axial movement of the translator rod. The translator rod is coupled to the probe assembly. In some implementations, the translation system includes a second translation ring that is configured to convert a rotational movement into an axial movement to deploy the central pin.
According to another aspect of the disclosure, a method for obtaining neurological activity data includes implanting a microelectrode device within a vicinity of a neurological target. The device includes an elongated shaft having an outer wall and a distal end. The elongated shaft defines an internal lumen and the outer wall defines a plurality of windows. The device also includes an end cap coupled with the distal end of the elongated shaft. The end cap has a frustum end projecting into the internal lumen of the elongated shaft. The device also includes a protective tube coupled with the outer surface of the elongated shaft. Portions of the protective tube cover a portion of each of the plurality of windows. The device further includes a probe assembly that includes a plurality of flexible pins. Each of the plurality of flexible pins includes a plurality of electrode sites. The method also includes deploying at least one of the plurality of flexible pins through a different one of the plurality of windows. The plurality of flexible pins can deploy at an exit angle defined by the frustum end of the end cap and a distal end of the protective tube. The method further includes recording the neurological activity using the plurality of electrode sites.
In some implementations, the method can include coupling the microelectrode device with a stereotactic apparatus. The plurality of flexible pins may be deployed by rotating a translator ring of the microelectrode device. In some implementations, the microelectrode device can include multiple translator rings to enable independent deployment of the flexible pins. The plurality of flexible pins can be retracted and the neurological probe can be removed from the neurological target. The position of the neurological probe within the brain of a subject can be determined responsive to the recorded neurological activity. The method can include coupling the neurological probe with a neural recording and neurostimulation device.
In some implementations, the protective tube is configured to substantially reduce a friction induced on the plurality of flexible pins during deployment through the plurality of windows. The protective tube can include a polymeric material. The protective tube and the plurality of flexible pins can include a same substrate material. A minimum of the exit angle can be defined by the frustum of the end cap, and a maximum of the exit angle can be defined by the distal end of the protective tube. In some implementations, the at least four windows are defined in the outer wall of the elongated shaft. In some implementations, the method includes sliding the plurality of flexible pins along the frustum end projecting into the internal lumen and the protective tube.
In some implementations, the method includes applying a rotational force to a rotational translation system. The rotational translation system can include a translator rod. The rotational translation system is configured to convert the rotational force applied to the rotational translation system into an axial movement of the translator rod. The translator rod can be coupled to the probe assembly.
The figures, described herein, are for illustration purposes. Various aspects of the described implementations may be shown exaggerated or enlarged to facilitate an understanding of the described implementations. In the drawings, like reference characters generally refer to like features, functionally similar or structurally similar elements throughout the various drawings. The drawings are not necessarily to scale. The drawings are not intended to limit the scope of the present teachings in any way. The systems and methods may be understood from the following illustrative description with reference to the following drawings in which:
The various concepts introduced above and discussed in greater detail below may be implemented in any of numerous ways, as the described concepts are not limited to any particular manner of implementation. Examples of specific implementations and applications are provided primarily for illustrative purposes. Medical devices discussed herein can perform neural recording and neurostimulation operations to interact electrically with tissue. In the case of neural recording, physiological measurements can be performed on neurological tissue to diagnose or treat a patient. In the case of neurostimulation, an electric charge can be transferred to the tissue in order to create a therapeutic outcome or to generate a diagnosis.
Described herein are microelectrode array devices, and methods of fabrication and use of the same, to provide localized and efficient electrical stimulation of a neurological target, such as individual neurons, groups of neurons, and neural tissue as may be located in an animal nervous system, such as deep within a human or animal brain. In small, difficult to find brain targets such as the Pedunculopontine Nucleus, or in targets that require localized levels of neural stimulation, such as the Subthalamic Nucleus, many microelectrodes are required in the brain region to find the target using electrophysiological recording. A higher number of microelectrodes can increase the chance of finding the neurons required for therapeutic stimulation. The microelectrode or group of microelectrodes that are closest to the target brain region can be used for chronic, therapeutic stimulation or inhibition.
The stimulation can be highly localized. In some implementations, the stimulation is localized by using small electrodes—for example between about 2 μm and about 2 mm in either of diameter or width. The relative spacing between such microelectrode elements can be between about 2 μm and about 2 mm. In some examples, microelectrodes of about 150 μm in diameter, with about a 1000 μm spacing are used to stimulate neural tissue. An array of such microelectrode elements may include one or more such elements (e.g., sixteen elements), each disposed at a respective position or site.
Smaller microelectrode elements can provide neurological stimulation that is highly localized and efficient because an array of such microelectrodes can identify the stimulation region of interest. For example, one or more microelectrode elements of such an array of microelectrode elements can be used to record neuronal activity in the vicinity of the detecting or recording microelectrode elements. Such refinement offered by the relatively small size or spacing of the microelectrode elements can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. A suitably dimensioned microelectrode array having multiple microelectrode elements positioned in a general vicinity of a neurological target, can be used to locate a precise neurological target without further repositioning, by identifying those one or more microelectrode elements located in a very specific region of the neurological target. The microelectrode array can be programmed to stimulate in a very specific region, for example, using a certain number of the microelectrode elements to actively stimulate the surrounding neurons or neuronal tissue, while other electrode elements of the array remain inactive.
In some embodiments, the microelectrode arrays are positioned in three-dimensional spaces, rather than implanted as linear arrays or two-dimensional arrays on films. The microelectrode arrays can be positioned along shafts, which radiate from a central lumen in order to cover the target tissue.
In some embodiments, an elongated device that includes microelectrode arrays having elements with relatively small size or spacing can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. For example, such a device configured with a linear array of microelectrodes positioned along a length of a distal end of the device can be placed into a patient's brain. The elements of the microelectrode array can envelop a region including the neurological target. Neurological activity can be independently detected by one or more of the microelectrode elements. The detected activity may be captured in a recorder or display device, allowing a clinician to identify which one or more of the microelectrode elements is positioned closest to the intended target. Knowing a respective location of each of the microelectrode elements along the device, and determining the distance to a reference, such as the patient's skull, a precise location of the target can be determined as the distance along a trajectory of the device. The distance is measured from the reference to the particular microelectrode element. The location of the target can be determined without any repositioning of the elongated device, thereby simplifying the medical procedure.
In some embodiments, the device is for acute intra-surgical use; being removed after the target has been located. The device can be replaced with a chronic probe or positioned at the determined target location. The device can be left in place as a chronic device, with the same microelectrodes or different ones used to record or stimulate the neurological target over an extended period of time.
In some implementations, the microelectrode device described herein includes inner and outer stent subassemblies. The outer stent subassembly can include an elongated shaft that defines an internal lumen. Multiple windows are defined in the wall of the elongated shaft towards elongated shaft's distal end. The microelectrode device also includes an end cap coupled with the distal end of the elongated shaft. A portion of the end cap includes a frustum end. The frustum end of the end cap projects into the internal lumen of the elongated shaft. A protective tube can be coupled with an outer surface of the elongated shaft. The protective tube can cover a portion of each of the windows. The microelectrode device can also include a probe assembly. The probe assembly is configured to slid through the internal lumen of the elongated shaft. The probe assembly can include flexible pins. Each of the flexible pins arc aligned with one of the windows defined in the elongated shaft such that the flexible pins can deploy through the window. The angle at which the flexible pins are deployed through the window is defined, at least in part, by the frustum end of the end cap and a distal end of the protective tube.
The outer stent sub-assembly 240 can provide a protective housing through which the inner stent sub-assembly 270 slides when driven by the translation system 300. In some implementations, the walls of the outer stent sub-assembly 240 form an elongated shaft that defines an internal lumen. The inner stent sub-assembly 270 can run through the internal lumen of the outer stent sub-assembly 240. The translation system 300 can be controlled by an operator and can enable the operator to select to what length each of the flexible pins of the microelectrode probe assembly is deployed.
With reference to
The microelectrode probe assembly 600 also includes a central pin 204 along the same longitudinal axis as the inner stent sub-assembly 270. The central pin 204 can be a flattened wire, and in some implementations, can be separate from the flexible pins 202. The central pin 204 can be coupled to the microelectrode probe assembly 600, by gluing or laser welding. The central pin 204 can include a plurality of electrodes 610 disposed along its shaft.
The components of the inner stent sub-assembly 270 can be manufactured from biocompatible materials. In some implementations, the materials are selected to withstand implantation for 24 hours. The material can also be selected such that they remain biocompatible for durations greater than 24 hours. The non-conducting components of the microelectrode probe assembly 600 can be manufactured from polyimide. The conducting components of the microelectrode probe assembly 600 (e.g., the electrodes 610) can be manufactured from platinum, platinum-iridium, and gold, for example.
The microelectrode probe assembly 600, the flexible pins 202, and the electrodes 610 can be sized and shaped for a specified neurological application. For example, the microelectrode probe assembly 600 may be at least partially placed within the central nervous system of a patient or other subject. The microelectrode probe assembly 600 may be placed within other parts or organs of the body, such as the epidural space of the spine, or other locations within the peripheral nervous system, or within an organ such as the liver or heart. The diameter and length of the microelectrode probe assembly 600 and flexible pins 202 may vary depending on the particular anatomical target. In some implementations, there are 2-4, 4-8, 8-12, and 12-16 flexible pins 202. In some implementations, each flexible pins 202 includes 2-4, 4-8, 8-12, 12-16, and 16-32 electrodes 610 per flexible pin 202.
The electrodes 610 can be sized or spaced to record from or stimulate neurons. The microelectrode probe assembly 600 can be used to detect or record neuronal activity at the neurological target. Neuronal activity naturally occurring within the neurological target gives rise to local electromagnetic fields that can be detected by one or more of the microelectrode elements of the microelectrode array. For example, electric fields produced by neurons can polarize one or more of the microelectrode elements. Such polarization gives rise to an electrical potential with respect to a reference, such as electrical ground, or another one of the electrodes 610. The detected electromagnetic fields are conducted from one or more of the electrodes 610 to a device external to the microelectrode device 100. The signals are conducted from the electrode 610 through the internal electrical conductors within the hollow stent tube 271. The external device that is connected to the microelectrode device 100 can be to one or more additional medical devices, which can further processing of the detected electrical activity. For example, the electrodes 610 can be coupled to a display device or recording device for displaying or recording electrical activity from the neurological target.
In some implementations, one or more of the electrodes 610 are used to electrically stimulate a neurological target. For example, one or more externally generated electrical signals can be applied to one or more of electrode 610. These electrical signals can be conducted through the internal electrical conductors to one or more of the electrodes 610. Depending on the amplitude and polarity of the electrical signals, an electrical field can be induced by the polarized electrodes 610. Electrical fields induced by such polarization can interact with one or more neurons at a target site.
Referring to
An end cap 262 can be coupled to the distal end of the outer stent tube 261. In some implementations, the end cap 262 is coupled to the outer stent tube 261 by gluing or laser welding. At its distal end, the outer wall of the outer stent tube 261 can define four windows 265. The windows 265 can be defined towards the distal end of the outer stent sub-assembly 240. When assembled, one window 265 can align with each of the flexible pins 202. Embodiments with more or fewer flexible pins 202 also include more or fewer, respectively, windows 265 such that each flexible pins 202 is associated with one window 265. The width 241 of each window 265 can be slightly wider (e.g., within 20%) than the width of the flexible pins 202 associated with the window 265.
As illustrated in
In some implementations, the flexible pins 202 and protective tube 250 are configured to reduce delamination of the flexible pins 202 during deployment. Delamination can be caused by friction between the flexible pins 202 and the outer walls of the windows 265. In some implementations, the possibility of delaminating the flexible pins 202 or microelectrode probe assembly 600 is reduced by sliding the flexible pins 202 along the frustum feature 263 and protective tube 250 rather than the walls of the windows 265. The protective tube 250 can be made out of a polymeric material that is the same or similar to the material used to manufacture the microelectrode probe assembly 600 or the flexible pins 202. The material can be selected to reduce the friction between the protective tube 250 and the frustum feature 263. The protective tube 250 and the frustum feature 263 can be manufactured to reduce abrasion during the deployment of the flexible pins 202 when compared to a device without a protective tube 250. In some implementations, the coefficient of friction of the flexible pins 202 against the protective tube 250 or the frustum feature 263 is between about 0.5 and about 0.01, between about 0.3 and about 0.01, or less than about 0.1. The coefficient of friction of the flexible pins 202 rubbing against the protective tube 250 constructed from a polyimide material may be about half as much when compared to a device where the flexible pins 250 rub against a stainless steel shaft. In some implementations, the coefficient of friction between the flexible pins 202 and the protective tube 250 is achieved because the outer faces of the flexible pins 202 and the protective tube 250 include the same substrate material, such as a polymeric material.
In some implementations, the protective tube 250 and the frustum feature 263 are manufactured from the same material as the flexible pins 202 to limit delamination. For example, the protective tube 250, the flexible pins 202, or the frustum feature 263 can be manufactured from polyimide. In some implementations, the selected material has a low coefficient of friction (COF). For example, the selected material can have a COF less than 0.5, less than 0.2, or less than 0.1. The relatively low COF enables the flexible pins 202 to smoothly slide out of the outer stent sub-assembly 240 during deployment. A low COF reduces the risk of delamination by reducing the force applied to the flexible pins 202 as they exit the outer stent sub-assembly 240.
Referring to
In some implementations, the controller does not have a translator ring 311, but rather the flexible pins 202 are deployed using a push-pull rod. For example, the push-pull rod can be coupled to the inner stent sub-assembly 270 along its linear axis. As an operator pushes or pulls the push-pull rod, the motion is directly translated to the inner stent sub-assembly 270 and the flexible pins 202.
The translation system 300 includes a removable back cap 310. Removing the back cap 310 provides access to the inner stent sub-assembly 270. The back cap 310 can be unscrewed by hand or with a tool. In some implementations, the translator ring 311 can also be removed from the translation system 300 after removal of the back cap 310. After removal of the back cap 310 and the translator ring 311, an operator is provided adequate access to remove the translator rod 330 and the inner stent sub-assembly 270. In some implementations, the removal of the back cap 310 is a safety mechanism that enables an operator to expose the internal components of the microelectrode device 100 and retract the inner stent sub-assembly 270 and flexible pins 202 in the event of a mechanical failure within the translation system 300. The method of dismantling the translation system 300 is described further in relation to
The translation system 300 can include a centering pin 321 and one or more guide pins 320. In some implementations, the centering pin 321 is used to index the microelectrode device 100 in a stereotactic apparatus (e.g., a stereotactic apparatus used in deep brain stimulation surgery). For example, the centering pin 321 and the guide pins 320 may be placed in a vertical arrangement within the stereotactic apparatus to indicate the initial position of the microelectrode device 100 relative to the stereotactic apparatus. In some implementations, the guide pins 320 form a key that can mate with a lock on a stereotactic apparatus. The guide pins 320 prevent any rotational movement that may be induced when using translator ring 311 and also assist with the initial indexing of the microelectrode device 100 to the stereotactic apparatus.
In some implementations, the centering pin 321 also reinforces the portion of the outer stent sub-assembly 240 where the microelectrode device 100 is typically clamped to the stereotactic apparatus. In some implementations, guide pins 320 are separated from one another (as measured by the distance between their longitudinal axes) by about 4 mm. In some implementations, each guide pin 320 is spaced (as measured by the distance between their longitudinal axes) about 2 mm from the centering pin 321. The interaction of the translation system 300 with the stereotactic apparatus is discussed further in relation to
The translation system 300 includes an indexing system to enable an operator to deploy the flexible pins 202 to predetermined lengths.
The distance from the central axis of the translation system 300 can be different for one or more of the ball bearing-spring system 433. For example,
In some implementations, one or more of the flexible pins 202 are independently controllable. The translation system 300 can include different translator rings 311 to control the deployment of each of the independently controllable flexible pins 202.
In some implementations, the microelectrode device is configured to prevent extraction of the electrode device while the flexible pins are deployed into a patients tissue. In some implementations, the translation system 300 of the microelectrode device includes alarms to alert the surgeon when the flexible pins are deployed or a mechanism that prevents removal of the microelectrode device when the flexible pins are deployed.
The translation system 300 can include a visual or an audible alarm system such as LEDs or buzzers. When the flexible pins are in their retracted state, the alarm can be off. When one of the flexible pins is deployed, the alarm can activate. For example, when the flexible pins are retracted a red LED on the translation system 300 may be off. However, when one of the flexible pins are deployed power may be provided to the red LED to alert the surgeon that he should not remove the microelectrode device from the patient. The translation system 300 can include a second LED, such as a green LED, that indicates to the surgeon that the flexible pins are retracted and it is safe to remove the microelectrode device from the patient. The alarm can be powered by battery resident within the translation system 300.
The visual alarm of the translation system 300 can include a mechanical indicator which exposes a colored ring, or other static visible indicator, when one or more flexible pins are deployed. This visible indicator can remain visible until each of the flexible pins are retracted. The mechanical indicator may not require a power source to generate the alert to the surgeon.
The translation system 300 can physically prevent the removal of the microelectrode device form the patient when one or more flexible pins are deployed.
In some implementations, a portion of the stereotactic frame 800 can be electrically or mechanically connected to the translation system 300 to prevent the displacement of the microelectrode device in certain conditions, such as when the flexible pins are deployed. The stereotactic frame 800 could electrically, or mechanically, block the movement of the microelectrode device with respect to the patient's brain, if the flexible pins are not in a safe position.
Various implementations of the microelectrode device have been described herein. These embodiments are giving by way of example and not to limit the scope of the present disclosure. The various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the disclosure.
Devices described herein as either acute or chronic may be used acutely or chronically. They may be implanted for such periods, such as during a surgery, and then removed. They may be implanted for extended periods, or indefinitely. Any devices described herein as being chronic may also be used acutely.
The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various aspects. Modifications and variations can be made without departing from its spirit and scope of this disclosure. Functionally equivalent methods and apparatuses may exist within the scope of this disclosure. Such modifications and variations are intended to fall within the scope of the appended claims. The subject matter of the present disclosure includes the full scope of equivalents to which it is entitled. This disclosure is not limited to particular methods, reagents, compounds compositions or biological systems, which can vary. The terminology used herein is for the purpose of describing particular embodiments, and is not intended to be limiting.
With respect to the use of substantially any plural or singular terms herein, the plural can include the singular or the singular can include the plural as is appropriate to the context or application.
In general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). Claims directed toward the described subject matter may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, such recitation can mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). Any disjunctive word or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, can contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” includes the possibilities of “A” or “B” or “A and B.”
In addition, where features or aspects of the disclosure are described in terms of Markush groups, the disclosure is also described in terms of any individual member or subgroup of members of the Markush group.
Any ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. Language such as “up to,” “at least,” “greater than,” “less than,” and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, a range includes each individual member.
One or more or any part thereof of the techniques described herein can be implemented in computer hardware or software, or a combination of both. The methods can be implemented in computer programs using standard programming techniques following the method and figures described herein. Program code is applied to input data to perform the functions described herein and generate output information. The output information is applied to one or more output devices such as a display monitor. Each program may be implemented in a high level procedural or object oriented programming language to communicate with a computer system. However, the programs can be implemented in assembly or machine language, if desired. In any case, the language can be a compiled or interpreted language. Moreover, the program can run on dedicated integrated circuits preprogrammed for that purpose.
Each such computer program can be stored on a storage medium or device (e.g., ROM or magnetic diskette) readable by a general or special purpose programmable computer, for configuring and operating the computer when the storage media or device is read by the computer to perform the procedures described herein. The computer program can also reside in cache or main memory during program execution. The analysis, preprocessing, and other methods described herein can also be implemented as a computer-readable storage medium, configured with a computer program, where the storage medium on configured causes a computer to operate in a specific and predefined manner to perform the functions described herein. In some embodiments, the computer readable media is tangible and substantially non-transitory in nature, e.g., such that the recorded information is recorded in a form other than solely as a propagating signal.
In some embodiments, a program product may include a signal bearing medium. The signal bearing medium may include one or more instructions that, when executed by, for example, a processor, may provide the functionality described above. In some implementations, signal bearing medium may encompass a computer-readable medium, such as, but not limited to, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, memory, etc. In some implementations, the signal bearing medium may encompass a recordable medium, such as, but not limited to, memory, read/write (R/W) CDs, R/W DVDs, etc. In some implementations, signal bearing medium may encompass a communications medium such as, but not limited to, a digital or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.). Thus, for example, the program product may be conveyed by an RF signal bearing medium, where the signal bearing medium is conveyed by a wireless communications medium (e.g., a wireless communications medium conforming with the IEEE 802.11 standard).
Any of the signals and signal processing techniques may be digital or analog in nature, or combinations thereof.
While certain embodiments of this disclosure have been particularly shown and described with references to preferred embodiments thereof, various changes in form and details may be made therein without departing from the scope of the disclosure.
The present application is a national stage application, filed under 35 U.S.C. § 371, of PCT Application No. PCT/IB2015/053610, filed May 15, 2015, entitled “DEVICE FOR INTERACTING WITH NEUROLOGICAL TISSUE AND METHODS OF MAKING AND USING THE SAME,” which claims priority to U.S. Application No. 61/994,359, filed May 16, 2014, all of which are hereby incorporated by reference in their entireties.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2015/053610 | 5/15/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2015/173787 | 11/19/2015 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4245645 | Arseneault et al. | Jan 1981 | A |
4550733 | Liss et al. | Nov 1985 | A |
4837049 | Byers et al. | Jun 1989 | A |
4917093 | Dufresne et al. | Apr 1990 | A |
4928297 | Tsutsui et al. | May 1990 | A |
4969468 | Byers et al. | Nov 1990 | A |
4989617 | Memberg et al. | Feb 1991 | A |
5095905 | Klepinski | Mar 1992 | A |
5215088 | Normann et al. | Jun 1993 | A |
5391250 | Cheney et al. | Feb 1995 | A |
5400784 | Durand et al. | Mar 1995 | A |
5419777 | Hofling | May 1995 | A |
5458629 | Baudino et al. | Oct 1995 | A |
5496369 | Howard, III | Mar 1996 | A |
5524338 | Martyniuk et al. | Jun 1996 | A |
5628317 | Starkebaum et al. | May 1997 | A |
5643330 | Holsheimer et al. | Jul 1997 | A |
5679355 | Alexander et al. | Oct 1997 | A |
5683422 | Rise | Nov 1997 | A |
5697651 | Fernandes | Dec 1997 | A |
5697975 | Howard et al. | Dec 1997 | A |
5702429 | King | Dec 1997 | A |
5713922 | King | Feb 1998 | A |
5713923 | Ward et al. | Feb 1998 | A |
5716377 | Rise et al. | Feb 1998 | A |
5727552 | Ryan | Mar 1998 | A |
5752979 | Benabid | May 1998 | A |
5755759 | Cogan | May 1998 | A |
5782798 | Rise | Jul 1998 | A |
5797970 | Pouvreau | Aug 1998 | A |
5800474 | Benabid et al. | Sep 1998 | A |
5800535 | Howard, III | Sep 1998 | A |
5814092 | King | Sep 1998 | A |
5824029 | Weijand et al. | Oct 1998 | A |
5792186 | Rise | Nov 1998 | A |
5833709 | Rise et al. | Nov 1998 | A |
5833714 | Loeb | Nov 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5893883 | Torgerson et al. | Apr 1999 | A |
5913882 | King | Jun 1999 | A |
5921924 | Avitall | Jul 1999 | A |
5927277 | Baudino et al. | Jul 1999 | A |
5941906 | Barreras et al. | Aug 1999 | A |
5957958 | Schulman et al. | Sep 1999 | A |
5975085 | Rise | Nov 1999 | A |
5978702 | Ward et al. | Nov 1999 | A |
5991668 | Leinders et al. | Nov 1999 | A |
6011996 | Gielen et al. | Jan 2000 | A |
6018682 | Rise | Jan 2000 | A |
6024095 | Stanley, III | Feb 2000 | A |
6033403 | Tu et al. | Mar 2000 | A |
6038480 | Hrdlicka et al. | Mar 2000 | A |
6050992 | Nichols | Apr 2000 | A |
6094598 | Elsberry et al. | Jul 2000 | A |
6104960 | Duysens et al. | Aug 2000 | A |
6109269 | Rise et al. | Aug 2000 | A |
6125300 | Weijand et al. | Sep 2000 | A |
6128537 | Rise | Oct 2000 | A |
6129685 | Howard, III | Oct 2000 | A |
6161047 | King et al. | Dec 2000 | A |
6205359 | Boveja | Mar 2001 | B1 |
6205361 | Kuzma et al. | Mar 2001 | B1 |
6216043 | Swanson et al. | Apr 2001 | B1 |
6227203 | Rise et al. | May 2001 | B1 |
6253109 | Gielen | Jun 2001 | B1 |
6253110 | Brabec et al. | Jun 2001 | B1 |
6263237 | Rise | Jul 2001 | B1 |
6266564 | Hill et al. | Jul 2001 | B1 |
6295476 | Schaenzer | Sep 2001 | B1 |
6301492 | Zonenshayn | Oct 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6330466 | Hofmann et al. | Dec 2001 | B1 |
6337997 | Rise | Jan 2002 | B1 |
6343226 | Sunde et al. | Jan 2002 | B1 |
6353762 | Baudino et al. | Mar 2002 | B1 |
6356784 | Lozano et al. | Mar 2002 | B1 |
6356786 | Rezai et al. | Mar 2002 | B1 |
6356787 | Rezai et al. | Mar 2002 | B1 |
6364875 | Stanley, III | Apr 2002 | B1 |
6366813 | DiLorenzo | Apr 2002 | B1 |
6374140 | Rise | Apr 2002 | B1 |
6375666 | Mische | Apr 2002 | B1 |
6379353 | Nichols | Apr 2002 | B1 |
6415187 | Kuzma et al. | Jul 2002 | B1 |
6434431 | Camps et al. | Aug 2002 | B1 |
6459936 | Fischell et al. | Oct 2002 | B2 |
6479999 | Demeester et al. | Nov 2002 | B1 |
6484059 | Gielen | Nov 2002 | B2 |
6493590 | Wessman et al. | Dec 2002 | B1 |
6510347 | Borkan | Jan 2003 | B2 |
6529774 | Greene | Mar 2003 | B1 |
6538443 | Morich et al. | Mar 2003 | B2 |
6549812 | Smits | Apr 2003 | B1 |
6556873 | Smits | Apr 2003 | B1 |
6560472 | Hill et al. | May 2003 | B2 |
6560486 | Osorio et al. | May 2003 | B1 |
6581046 | Ahissar | Jun 2003 | B1 |
6587733 | Cross et al. | Jul 2003 | B1 |
6591128 | Wu et al. | Jul 2003 | B1 |
6594524 | Esteller et al. | Jul 2003 | B2 |
6597953 | Boling | Jul 2003 | B2 |
6643552 | Edell et al. | Nov 2003 | B2 |
6671544 | Baudino | Dec 2003 | B2 |
6675046 | Holsheimer | Jan 2004 | B2 |
6687538 | Hrdlicka et al. | Feb 2004 | B1 |
6690973 | Hill et al. | Feb 2004 | B2 |
6708064 | Rezai | Mar 2004 | B2 |
6718208 | Hill et al. | Apr 2004 | B2 |
6718211 | Smits | Apr 2004 | B2 |
6741893 | Smits | May 2004 | B2 |
6745079 | King | Jun 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
6795737 | Gielen et al. | Sep 2004 | B2 |
6804552 | Thompson et al. | Oct 2004 | B2 |
6818396 | Bloch et al. | Nov 2004 | B1 |
6829498 | Kipke et al. | Dec 2004 | B2 |
6850802 | Holsheimer | Feb 2005 | B2 |
6871098 | Nuttin et al. | Mar 2005 | B2 |
6882881 | Lesser et al. | Apr 2005 | B1 |
6892097 | Holsheimer | May 2005 | B2 |
6892438 | Hill et al. | May 2005 | B1 |
6904306 | Wu et al. | Jun 2005 | B1 |
6909920 | Lokhoff et al. | Jun 2005 | B2 |
6920359 | Meadows et al. | Jul 2005 | B2 |
6928320 | King | Aug 2005 | B2 |
6950706 | Rodriguez et al. | Sep 2005 | B2 |
6950709 | Baudino | Sep 2005 | B2 |
6978171 | Goetz et al. | Dec 2005 | B2 |
6978178 | Sommer et al. | Dec 2005 | B2 |
6999819 | Swoyer et al. | Feb 2006 | B2 |
7006859 | Osorio et al. | Feb 2006 | B1 |
7010351 | Firlik et al. | Mar 2006 | B2 |
7010356 | Jog et al. | Mar 2006 | B2 |
7024246 | Acosta et al. | Apr 2006 | B2 |
7035690 | Goetz | Apr 2006 | B2 |
7047082 | Schrom et al. | May 2006 | B1 |
7047084 | Erickson et al. | May 2006 | B2 |
7050856 | Stypulkowski | May 2006 | B2 |
7051419 | Schrom et al. | May 2006 | B2 |
7061240 | Ham et al. | Jun 2006 | B2 |
7063767 | Tyson et al. | Jun 2006 | B1 |
7076292 | Forsberg | Jul 2006 | B2 |
7077822 | Howard, III | Jul 2006 | B1 |
7107104 | Keravel et al. | Sep 2006 | B2 |
7133718 | Bakken et al. | Nov 2006 | B2 |
7146222 | Boling | Dec 2006 | B2 |
7151961 | Whitehurst et al. | Dec 2006 | B1 |
7174219 | Wahlstrand et al. | Feb 2007 | B2 |
7177701 | Pianca | Feb 2007 | B1 |
7181288 | Rezai et al. | Feb 2007 | B1 |
7184829 | Hill et al. | Feb 2007 | B2 |
7187978 | Malek et al. | Mar 2007 | B2 |
7191016 | Marshall et al. | Mar 2007 | B2 |
7191018 | Gielen et al. | Mar 2007 | B2 |
7198626 | Lee | Apr 2007 | B2 |
7200439 | Zdeblick et al. | Apr 2007 | B2 |
7203548 | Whitehurst et al. | Apr 2007 | B2 |
7204798 | Zdeblick et al. | Apr 2007 | B2 |
7204833 | Osorio et al. | Apr 2007 | B1 |
7209787 | DiLorenzo | Apr 2007 | B2 |
7212851 | Donoghue et al. | May 2007 | B2 |
7212867 | Van Venrooij et al. | May 2007 | B2 |
7214189 | Zdeblick | May 2007 | B2 |
7216000 | Sieracki et al. | May 2007 | B2 |
7216001 | Hacker et al. | May 2007 | B2 |
7231256 | Wahlstrand et al. | Jun 2007 | B2 |
7236822 | Dobak, III | Jun 2007 | B2 |
7242984 | DiLorenzo | Jul 2007 | B2 |
7276061 | Schaer et al. | Oct 2007 | B2 |
7280867 | Frei et al. | Oct 2007 | B2 |
7282030 | Frei et al. | Oct 2007 | B2 |
7282050 | Starkebaum et al. | Oct 2007 | B2 |
7286878 | Stypulkowski | Oct 2007 | B2 |
7286882 | Cole | Oct 2007 | B2 |
7288066 | Drew | Oct 2007 | B2 |
7289851 | Gunderson et al. | Oct 2007 | B2 |
7289852 | Helfinstine et al. | Oct 2007 | B2 |
7295880 | Gielen | Nov 2007 | B2 |
7298143 | Jaermann et al. | Nov 2007 | B2 |
7307223 | Tyson et al. | Dec 2007 | B2 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7313440 | Miesel | Dec 2007 | B2 |
7315759 | Markowitz et al. | Jan 2008 | B2 |
7317947 | Wahlstrand et al. | Jan 2008 | B2 |
7317948 | King et al. | Jan 2008 | B1 |
7319899 | Keizer | Jan 2008 | B2 |
7319904 | Cross et al. | Jan 2008 | B2 |
7321798 | Muhlenberg et al. | Jan 2008 | B2 |
7321837 | Osorio et al. | Jan 2008 | B2 |
7322832 | Kronich et al. | Jan 2008 | B2 |
7328057 | Freas et al. | Feb 2008 | B2 |
7328068 | Spinelli et al. | Feb 2008 | B2 |
7328069 | Gerber | Feb 2008 | B2 |
7330760 | Heruth et al. | Feb 2008 | B2 |
7337010 | Howard et al. | Feb 2008 | B2 |
7343206 | Sage et al. | Mar 2008 | B2 |
7346395 | Lozano et al. | Mar 2008 | B2 |
7356369 | Phillips et al. | Apr 2008 | B2 |
7359837 | Drew | Apr 2008 | B2 |
7366572 | Heruth et al. | Apr 2008 | B2 |
7367956 | King | May 2008 | B2 |
7369891 | Augustijn et al. | May 2008 | B2 |
7369893 | Gunderson | May 2008 | B2 |
7369894 | Gerber | May 2008 | B2 |
7385443 | Denison | Jun 2008 | B1 |
7388378 | Gray et al. | Jun 2008 | B2 |
7389147 | Wahlstrand et al. | Jun 2008 | B2 |
7390311 | Hildebrand et al. | Jun 2008 | B2 |
7391257 | Denison et al. | Jun 2008 | B1 |
7392089 | Wahlstrand et al. | Jun 2008 | B2 |
7395113 | Heruth et al. | Jul 2008 | B2 |
7400927 | Litvin | Jul 2008 | B1 |
7403820 | DiLorenzo | Jul 2008 | B2 |
7406351 | Wesselink | Jul 2008 | B2 |
7418292 | Shafer | Aug 2008 | B2 |
7421297 | Giftakis et al. | Sep 2008 | B2 |
7427280 | Gerber | Sep 2008 | B2 |
7429938 | Corndorf | Sep 2008 | B1 |
7433734 | King | Oct 2008 | B2 |
7442183 | Baudino et al. | Oct 2008 | B2 |
7447545 | Heruth et al. | Nov 2008 | B2 |
7450996 | MacDonald et al. | Nov 2008 | B2 |
7463917 | Martinez | Dec 2008 | B2 |
7463928 | Lee et al. | Dec 2008 | B2 |
7474247 | Heinks et al. | Jan 2009 | B1 |
7479910 | Heinks et al. | Jan 2009 | B1 |
7483748 | Torgerson et al. | Jan 2009 | B2 |
7489966 | Leinders et al. | Feb 2009 | B2 |
7489970 | Lee et al. | Feb 2009 | B2 |
7491181 | Heruth et al. | Feb 2009 | B2 |
7497844 | Spear et al. | Mar 2009 | B2 |
7497863 | Solar et al. | Mar 2009 | B2 |
7502217 | Zhao et al. | Mar 2009 | B2 |
7505815 | Lee et al. | Mar 2009 | B2 |
7505869 | Hartlaub | Mar 2009 | B2 |
7515961 | Germanson et al. | Apr 2009 | B2 |
7519431 | Goetz et al. | Apr 2009 | B2 |
7519432 | Bolea et al. | Apr 2009 | B2 |
7520890 | Phillips | Apr 2009 | B2 |
7526339 | Lahti et al. | Apr 2009 | B2 |
7526340 | Drew | Apr 2009 | B2 |
7526341 | Goetz et al. | Apr 2009 | B2 |
7529582 | DiLorenzo | May 2009 | B1 |
7529586 | Wahlstrand et al. | May 2009 | B2 |
7542803 | Heruth et al. | Jun 2009 | B2 |
7546164 | King | Jun 2009 | B2 |
7546166 | Michels et al. | Jun 2009 | B2 |
7548775 | Kipke et al. | Jun 2009 | B2 |
7548786 | Lee et al. | Jun 2009 | B2 |
7551951 | Osorio et al. | Jun 2009 | B1 |
7551960 | Forsberg et al. | Jun 2009 | B2 |
7555345 | Wahlstrand et al. | Jun 2009 | B2 |
7561921 | Phillips et al. | Jul 2009 | B2 |
7563141 | Alexander et al. | Jul 2009 | B2 |
7563541 | Howard et al. | Jul 2009 | B2 |
7578819 | Bleich et al. | Aug 2009 | B2 |
7580756 | Schulte et al. | Aug 2009 | B2 |
7582387 | Howard et al. | Sep 2009 | B2 |
7590451 | Tronnes et al. | Sep 2009 | B2 |
7590453 | Heruth et al. | Sep 2009 | B2 |
7590455 | Heruth et al. | Sep 2009 | B2 |
7591970 | Olson | Sep 2009 | B2 |
7594828 | Alexander et al. | Sep 2009 | B2 |
7594889 | St. Ores et al. | Sep 2009 | B2 |
7596399 | Singhal et al. | Sep 2009 | B2 |
7596408 | Singhal et al. | Sep 2009 | B2 |
7596415 | Brabec et al. | Sep 2009 | B2 |
7599730 | Hunter et al. | Oct 2009 | B2 |
7603161 | Wurmfeld et al. | Oct 2009 | B2 |
7603177 | Sieracki et al. | Oct 2009 | B2 |
7604629 | Gerber et al. | Oct 2009 | B2 |
7604644 | Schulte et al. | Oct 2009 | B2 |
7608458 | Soykan et al. | Oct 2009 | B2 |
7610083 | Drew et al. | Oct 2009 | B2 |
7611483 | Gerber et al. | Nov 2009 | B2 |
7614743 | Geiger | Nov 2009 | B2 |
7615015 | Coleman | Nov 2009 | B2 |
7616998 | Nuttin et al. | Nov 2009 | B2 |
7617002 | Goetz | Nov 2009 | B2 |
7620454 | Dinsmoor et al. | Nov 2009 | B2 |
7622303 | Soykan et al. | Nov 2009 | B2 |
7622988 | Denison et al. | Nov 2009 | B2 |
7623053 | Terry et al. | Nov 2009 | B2 |
7623918 | Goetz | Nov 2009 | B2 |
7623919 | Goetz et al. | Nov 2009 | B2 |
7623923 | Gerber et al. | Nov 2009 | B2 |
7623930 | Zeijlemaker et al. | Nov 2009 | B2 |
7624293 | Osorio et al. | Nov 2009 | B2 |
7628780 | Bonner et al. | Dec 2009 | B2 |
7631415 | Phillips et al. | Dec 2009 | B2 |
7632225 | Stypulkowski | Dec 2009 | B2 |
7635541 | Scott et al. | Dec 2009 | B2 |
7637867 | Zdeblick | Dec 2009 | B2 |
7640059 | Forsberg et al. | Dec 2009 | B2 |
7640060 | Zdeblick | Dec 2009 | B2 |
7641992 | Howard et al. | Jan 2010 | B2 |
7642013 | Howard et al. | Jan 2010 | B2 |
7647111 | Ries et al. | Jan 2010 | B2 |
7647116 | Bauhahn | Jan 2010 | B2 |
7647117 | Bauhahn | Jan 2010 | B2 |
7647121 | Wahlstrand et al. | Jan 2010 | B2 |
7650291 | Rosenfeld et al. | Jan 2010 | B2 |
7653433 | Lozano et al. | Jan 2010 | B2 |
7657318 | King et al. | Feb 2010 | B2 |
7657319 | Goetz et al. | Feb 2010 | B2 |
7660620 | Zeijlemaker et al. | Feb 2010 | B2 |
7660630 | Dudding et al. | Feb 2010 | B2 |
7662140 | Heruth et al. | Feb 2010 | B2 |
7662509 | Howard et al. | Feb 2010 | B2 |
7663066 | Tyson et al. | Feb 2010 | B2 |
7664551 | Cigaina | Feb 2010 | B2 |
7664552 | Wahlstrand et al. | Feb 2010 | B2 |
7668601 | Hegland et al. | Feb 2010 | B2 |
7671594 | Gray | Mar 2010 | B2 |
7676271 | Wahlstrand et al. | Mar 2010 | B2 |
7676273 | Goetz et al. | Mar 2010 | B2 |
7676274 | Hung et al. | Mar 2010 | B2 |
7680540 | Jensen et al. | Mar 2010 | B2 |
7682355 | Gerber et al. | Mar 2010 | B2 |
7682745 | Howard et al. | Mar 2010 | B2 |
7684860 | Wahlstrand et al. | Mar 2010 | B2 |
7684866 | Fowler et al. | Mar 2010 | B2 |
7684873 | Gerber | Mar 2010 | B2 |
7689289 | King | Mar 2010 | B2 |
7697972 | Verard et al. | Apr 2010 | B2 |
7697995 | Cross et al. | Apr 2010 | B2 |
7706124 | Zhao et al. | Apr 2010 | B2 |
7706889 | Gerber et al. | Apr 2010 | B2 |
7711421 | Shafer et al. | May 2010 | B2 |
7711428 | Janzig et al. | May 2010 | B2 |
7711436 | Stone | May 2010 | B2 |
7713194 | Zdeblick | May 2010 | B2 |
7713195 | Zdeblick | May 2010 | B2 |
7720548 | King | May 2010 | B2 |
7729768 | White et al. | Jun 2010 | B2 |
7729780 | Vardiman | Jun 2010 | B2 |
7738958 | Zdeblick et al. | Jun 2010 | B2 |
7742823 | King et al. | Jun 2010 | B2 |
7756588 | Jog et al. | Jul 2010 | B2 |
7765012 | Gerber | Jul 2010 | B2 |
7769472 | Gerber | Aug 2010 | B2 |
7797029 | Gibson et al. | Sep 2010 | B2 |
7822482 | Gerber | Oct 2010 | B2 |
7822483 | Stone et al. | Oct 2010 | B2 |
7853303 | Nikumb et al. | Dec 2010 | B2 |
7877149 | Zdeblick | Jan 2011 | B2 |
7899539 | Whitehurst et al. | Mar 2011 | B2 |
7925329 | Zdeblick et al. | Apr 2011 | B2 |
7930035 | Dilorenzo | Apr 2011 | B2 |
7935056 | Zdeblick | May 2011 | B2 |
7941202 | Hetke et al. | May 2011 | B2 |
7945329 | Bedenbaugh | May 2011 | B2 |
7945336 | Sauter-Starace et al. | May 2011 | B2 |
7969161 | Behzadi et al. | Jun 2011 | B2 |
7974705 | Zdeblick et al. | Jul 2011 | B2 |
7978064 | Zdeblick et al. | Jul 2011 | B2 |
7979105 | Kipke et al. | Jul 2011 | B2 |
7983751 | Zdeblick et al. | Jul 2011 | B2 |
7991481 | Benabid et al. | Aug 2011 | B2 |
8000794 | Lozano | Aug 2011 | B2 |
8000808 | Hegland et al. | Aug 2011 | B2 |
8010202 | Shah et al. | Aug 2011 | B2 |
8024022 | Schulman et al. | Sep 2011 | B2 |
8032224 | Miesel et al. | Oct 2011 | B2 |
8036737 | Goetz et al. | Oct 2011 | B2 |
8036743 | Savage et al. | Oct 2011 | B2 |
8036748 | Zdeblick et al. | Oct 2011 | B2 |
8055334 | Savage et al. | Nov 2011 | B2 |
8055353 | Kreidler et al. | Nov 2011 | B2 |
8090450 | Swoyer et al. | Jan 2012 | B2 |
8099170 | Jensen et al. | Jan 2012 | B2 |
8108049 | King | Jan 2012 | B2 |
8114021 | Robertson et al. | Feb 2012 | B2 |
8115618 | Robertson et al. | Feb 2012 | B2 |
8121687 | Jensen et al. | Feb 2012 | B2 |
8121702 | King | Feb 2012 | B2 |
8123684 | Zdeblick | Feb 2012 | B2 |
8170676 | Greenberg et al. | May 2012 | B2 |
8171621 | Swanson et al. | May 2012 | B2 |
8172762 | Robertson | May 2012 | B2 |
8187161 | Li et al. | May 2012 | B2 |
8195308 | Frank et al. | Jun 2012 | B2 |
8204586 | Zdeblick | Jun 2012 | B2 |
8224417 | Vetter | Jul 2012 | B2 |
8224462 | Westlund et al. | Jul 2012 | B2 |
8244377 | Pianca et al. | Aug 2012 | B1 |
8258962 | Robertson et al. | Sep 2012 | B2 |
8261428 | Fang et al. | Sep 2012 | B2 |
8271094 | Moffitt et al. | Sep 2012 | B1 |
8280514 | Lozano et al. | Oct 2012 | B2 |
8295943 | Eggen et al. | Oct 2012 | B2 |
8315686 | Llinas et al. | Nov 2012 | B2 |
8321025 | Bedenbaugh | Nov 2012 | B2 |
8332020 | Zdeblick | Dec 2012 | B2 |
8332046 | Anderson et al. | Dec 2012 | B2 |
8355768 | Masmanidis et al. | Jan 2013 | B2 |
8374703 | Imran | Feb 2013 | B2 |
8412347 | Zdeblick | Apr 2013 | B2 |
8463353 | Seymour | Jun 2013 | B2 |
8463398 | Jackson et al. | Jun 2013 | B2 |
8467877 | Imran | Jun 2013 | B2 |
8473061 | Moffitt et al. | Jun 2013 | B2 |
8473069 | Bi et al. | Jun 2013 | B2 |
8489203 | Ortmann | Jul 2013 | B2 |
8509872 | Lee et al. | Aug 2013 | B2 |
8509876 | Karmarkar | Aug 2013 | B2 |
8509920 | Wahlstrand et al. | Aug 2013 | B2 |
8560085 | Moffitt et al. | Oct 2013 | B2 |
8565894 | Vetter et al. | Oct 2013 | B2 |
8571665 | Moffitt et al. | Oct 2013 | B2 |
8583253 | Shi et al. | Nov 2013 | B1 |
8620452 | King et al. | Dec 2013 | B2 |
8626312 | King et al. | Jan 2014 | B2 |
8634934 | Kokones et al. | Jan 2014 | B2 |
8644903 | Osa et al. | Feb 2014 | B1 |
8649879 | Digiore et al. | Feb 2014 | B2 |
8666509 | Howard et al. | Mar 2014 | B2 |
8694105 | Martens et al. | Apr 2014 | B2 |
8694123 | Wahlstrand et al. | Apr 2014 | B2 |
8694127 | Pianca et al. | Apr 2014 | B2 |
8731673 | Vetter et al. | May 2014 | B2 |
8738154 | Zdeblick et al. | May 2014 | B2 |
8744596 | Howard | Jun 2014 | B2 |
8755906 | Moffitt et al. | Jun 2014 | B2 |
8762065 | Dilorenzo | Jun 2014 | B2 |
8774891 | Osa et al. | Jul 2014 | B1 |
8788056 | King et al. | Jul 2014 | B2 |
8788063 | Chen | Jul 2014 | B2 |
8788064 | Mercanzini et al. | Jul 2014 | B2 |
8792993 | Pianca et al. | Jul 2014 | B2 |
8800140 | Hetke et al. | Aug 2014 | B2 |
8825175 | King | Sep 2014 | B2 |
8831739 | McCreery et al. | Sep 2014 | B2 |
8831742 | Pianca et al. | Sep 2014 | B2 |
8849369 | Cogan et al. | Sep 2014 | B2 |
8849415 | Bedenbaugh | Sep 2014 | B2 |
8862242 | Pianca | Oct 2014 | B2 |
8874232 | Chen | Oct 2014 | B2 |
8875391 | Pianca et al. | Nov 2014 | B2 |
8897891 | Romero | Nov 2014 | B2 |
8923982 | Howard | Dec 2014 | B2 |
8934965 | Rogers et al. | Jan 2015 | B2 |
8934980 | Pless et al. | Jan 2015 | B2 |
8938300 | Rosero | Jan 2015 | B2 |
8938308 | Meadows | Jan 2015 | B2 |
8958862 | Hetke et al. | Feb 2015 | B2 |
8968331 | Sochor | Mar 2015 | B1 |
8977335 | Putz | Mar 2015 | B2 |
8977367 | Elahi et al. | Mar 2015 | B2 |
8989864 | Funderburk et al. | Mar 2015 | B2 |
9008747 | Seymour et al. | Apr 2015 | B2 |
9014796 | Kipke et al. | Apr 2015 | B2 |
9044590 | Greenberg et al. | Jun 2015 | B2 |
9061134 | Askin et al. | Jun 2015 | B2 |
9079013 | Digiore et al. | Jul 2015 | B2 |
9089689 | Govea | Jul 2015 | B2 |
9089690 | Greenberg et al. | Jul 2015 | B2 |
9095267 | Halpern et al. | Aug 2015 | B2 |
9149630 | Howard et al. | Oct 2015 | B2 |
9211401 | Frewin et al. | Dec 2015 | B2 |
9211402 | Moffitt et al. | Dec 2015 | B2 |
9220897 | Perryman et al. | Dec 2015 | B2 |
9227050 | Romero | Jan 2016 | B2 |
9248272 | Romero | Feb 2016 | B2 |
9248275 | Digiore et al. | Feb 2016 | B2 |
9265465 | Najafi et al. | Feb 2016 | B2 |
9265928 | Pellinen et al. | Feb 2016 | B2 |
9283375 | Moffitt et al. | Mar 2016 | B2 |
9289151 | Kipke et al. | Mar 2016 | B2 |
9289596 | Leven | Mar 2016 | B2 |
9295830 | Pianca | Mar 2016 | B2 |
9314614 | Bedenbaugh | Apr 2016 | B2 |
9358398 | Moffitt et al. | Jun 2016 | B2 |
9364659 | Rao | Jun 2016 | B1 |
9381347 | Howard et al. | Jul 2016 | B2 |
9381348 | Romero et al. | Jul 2016 | B2 |
9381356 | Parker et al. | Jul 2016 | B2 |
9399128 | Tooker et al. | Jul 2016 | B2 |
9427567 | Romero | Aug 2016 | B2 |
9474895 | Digiore et al. | Oct 2016 | B2 |
9498620 | Romero et al. | Nov 2016 | B2 |
9517020 | Shacham-Diamand et al. | Dec 2016 | B2 |
9592377 | Greenberg et al. | Mar 2017 | B2 |
9604051 | Vetter et al. | Mar 2017 | B2 |
9662494 | Young | May 2017 | B2 |
9700715 | Dou | Jul 2017 | B2 |
9743878 | Drew | Aug 2017 | B2 |
9775983 | Digiore et al. | Oct 2017 | B2 |
9775988 | Govea et al. | Oct 2017 | B2 |
9827413 | Barker et al. | Nov 2017 | B2 |
9833611 | Govea et al. | Dec 2017 | B2 |
9855428 | Henry et al. | Jan 2018 | B2 |
9861288 | Ma et al. | Jan 2018 | B2 |
9925368 | Ryu et al. | Mar 2018 | B2 |
10046165 | Frewin et al. | Aug 2018 | B2 |
20010051802 | Woloszko | Dec 2001 | A1 |
20010051819 | Fischell et al. | Dec 2001 | A1 |
20020062143 | Baudino et al. | May 2002 | A1 |
20020116042 | Boling | Aug 2002 | A1 |
20030004553 | Grill et al. | Jan 2003 | A1 |
20030023282 | Barrett et al. | Jan 2003 | A1 |
20030036780 | Barrett et al. | Feb 2003 | A1 |
20030060822 | Schaer et al. | Mar 2003 | A1 |
20030083724 | Jog et al. | May 2003 | A1 |
20030100823 | Kipke et al. | May 2003 | A1 |
20030135253 | Kokones et al. | Jul 2003 | A1 |
20030176892 | Shalev | Sep 2003 | A1 |
20040002635 | Hargrove et al. | Jan 2004 | A1 |
20040015205 | Whitehurst et al. | Jan 2004 | A1 |
20040039434 | Schrom et al. | Feb 2004 | A1 |
20040102828 | Lowry et al. | May 2004 | A1 |
20040122335 | Sackellares et al. | Jun 2004 | A1 |
20040133390 | Osorio et al. | Jul 2004 | A1 |
20040138517 | Osorio et al. | Jul 2004 | A1 |
20040138536 | Frei et al. | Jul 2004 | A1 |
20040138720 | Naisberg et al. | Jul 2004 | A1 |
20040138722 | Carroll et al. | Jul 2004 | A1 |
20040152958 | Frei et al. | Aug 2004 | A1 |
20040172089 | Whitehurst et al. | Sep 2004 | A1 |
20040193021 | Zdeblick et al. | Sep 2004 | A1 |
20040215288 | Lee et al. | Oct 2004 | A1 |
20040220637 | Zdeblick et al. | Nov 2004 | A1 |
20040225335 | Whitehurst et al. | Nov 2004 | A1 |
20040243011 | Plaza | Dec 2004 | A1 |
20040249417 | Ransbury et al. | Dec 2004 | A1 |
20040254483 | Zdeblick et al. | Dec 2004 | A1 |
20050004627 | Gibson et al. | Jan 2005 | A1 |
20050008660 | Kipke et al. | Jan 2005 | A1 |
20050010261 | Luders et al. | Jan 2005 | A1 |
20050021103 | DiLorenzo | Jan 2005 | A1 |
20050027284 | Lozano et al. | Feb 2005 | A1 |
20050033136 | Govari et al. | Feb 2005 | A1 |
20050038489 | Grill | Feb 2005 | A1 |
20050049655 | Boveja et al. | Mar 2005 | A1 |
20050070971 | Fowler et al. | Mar 2005 | A1 |
20050075681 | Rezai et al. | Apr 2005 | A1 |
20050113882 | Cameron et al. | May 2005 | A1 |
20050137647 | Wallace et al. | Jun 2005 | A1 |
20050143790 | Kipke et al. | Jun 2005 | A1 |
20050154425 | Boveja et al. | Jul 2005 | A1 |
20050171522 | Christopherson | Aug 2005 | A1 |
20050171558 | Abovitz et al. | Aug 2005 | A1 |
20050182455 | Thrope et al. | Aug 2005 | A1 |
20050209511 | Heruth et al. | Sep 2005 | A1 |
20050209513 | Heruth et al. | Sep 2005 | A1 |
20050209643 | Heruth et al. | Sep 2005 | A1 |
20050222642 | Przybyszewski et al. | Oct 2005 | A1 |
20050240242 | DiLorenzo | Oct 2005 | A1 |
20050245988 | Miesel | Nov 2005 | A1 |
20060004422 | De Ridder | Jan 2006 | A1 |
20060030897 | Gilmer et al. | Feb 2006 | A1 |
20060041295 | Osypka | Feb 2006 | A1 |
20060049957 | Surgenor et al. | Mar 2006 | A1 |
20060058588 | Zdeblick | Mar 2006 | A1 |
20060058727 | Bernabei | Mar 2006 | A1 |
20060058855 | Gill | Mar 2006 | A1 |
20060084965 | Young | Apr 2006 | A1 |
20060095029 | Young | May 2006 | A1 |
20060095105 | Jog et al. | May 2006 | A1 |
20060116581 | Zdeblick et al. | Jun 2006 | A1 |
20060129203 | Garabedian et al. | Jun 2006 | A1 |
20060135877 | Giftakis et al. | Jun 2006 | A1 |
20060149336 | Meadows | Jul 2006 | A1 |
20060149337 | John | Jul 2006 | A1 |
20060167497 | Armstrong et al. | Jul 2006 | A1 |
20060173263 | He et al. | Aug 2006 | A1 |
20060173510 | Besio et al. | Aug 2006 | A1 |
20060178709 | Foster et al. | Aug 2006 | A1 |
20060184060 | Belalcazar et al. | Aug 2006 | A1 |
20060195154 | Jaax et al. | Aug 2006 | A1 |
20060200206 | Firlik et al. | Sep 2006 | A1 |
20060212090 | Lozano et al. | Sep 2006 | A1 |
20060241717 | Whitehurst et al. | Oct 2006 | A1 |
20060258951 | Bleich et al. | Nov 2006 | A1 |
20060264777 | Drew | Nov 2006 | A1 |
20060276866 | McCreery | Dec 2006 | A1 |
20060282014 | Kipke et al. | Dec 2006 | A1 |
20060293720 | DiLorenzo | Dec 2006 | A1 |
20060293721 | Tarver et al. | Dec 2006 | A1 |
20070027498 | Maschino et al. | Feb 2007 | A1 |
20070027500 | Maschino et al. | Feb 2007 | A1 |
20070027514 | Gerber | Feb 2007 | A1 |
20070043268 | Russell | Feb 2007 | A1 |
20070060974 | Lozano | Mar 2007 | A1 |
20070067002 | Lozano | Mar 2007 | A1 |
20070067003 | Sanchez et al. | Mar 2007 | A1 |
20070088403 | Wyler et al. | Apr 2007 | A1 |
20070088404 | Wyler et al. | Apr 2007 | A1 |
20070093870 | Maschino | Apr 2007 | A1 |
20070100389 | Jaax et al. | May 2007 | A1 |
20070100392 | Maschino et al. | May 2007 | A1 |
20070100393 | Whitehurst et al. | May 2007 | A1 |
20070100398 | Sloan | May 2007 | A1 |
20070106143 | Flaherty | May 2007 | A1 |
20070123765 | Hetke et al. | May 2007 | A1 |
20070123944 | Zdeblick | May 2007 | A1 |
20070135721 | Zdeblick | Jun 2007 | A1 |
20070142872 | Mickle et al. | Jun 2007 | A1 |
20070150024 | Leyde et al. | Jun 2007 | A1 |
20070173890 | Armstrong | Jul 2007 | A1 |
20070173896 | Zdeblick | Jul 2007 | A1 |
20070173897 | Zdeblick | Jul 2007 | A1 |
20070173901 | Reeve | Jul 2007 | A1 |
20070173908 | Begnaud | Jul 2007 | A1 |
20070179558 | Gliner et al. | Aug 2007 | A1 |
20070179569 | Zdeblick | Aug 2007 | A1 |
20070185537 | Zdeblick | Aug 2007 | A1 |
20070185544 | Dawant et al. | Aug 2007 | A1 |
20070185548 | Zdeblick | Aug 2007 | A1 |
20070185549 | Zdeblick | Aug 2007 | A1 |
20070197892 | Shen et al. | Aug 2007 | A1 |
20070203537 | Goetz et al. | Aug 2007 | A1 |
20070203546 | Stone et al. | Aug 2007 | A1 |
20070208394 | King et al. | Sep 2007 | A1 |
20070213784 | Pless | Sep 2007 | A1 |
20070213785 | Osorio et al. | Sep 2007 | A1 |
20070213786 | Sackellares et al. | Sep 2007 | A1 |
20070219591 | Zdeblick et al. | Sep 2007 | A1 |
20070225674 | Molnar et al. | Sep 2007 | A1 |
20070225773 | Shen et al. | Sep 2007 | A1 |
20070225774 | Eskandar et al. | Sep 2007 | A1 |
20070233192 | Craig | Oct 2007 | A1 |
20070249953 | Frei et al. | Oct 2007 | A1 |
20070249954 | Virag et al. | Oct 2007 | A1 |
20070250133 | Carlson et al. | Oct 2007 | A1 |
20070255323 | Werder et al. | Nov 2007 | A1 |
20070255338 | Wahlstrand | Nov 2007 | A1 |
20070255374 | Kolafa et al. | Nov 2007 | A1 |
20070255531 | Drew | Nov 2007 | A1 |
20070265683 | Ehrlich | Nov 2007 | A1 |
20070282389 | Moxon et al. | Dec 2007 | A1 |
20070293908 | Cowan et al. | Dec 2007 | A1 |
20080021514 | Pless | Jan 2008 | A1 |
20080021517 | Dietrich | Jan 2008 | A1 |
20080027289 | Zdeblick | Jan 2008 | A1 |
20080027487 | Patel et al. | Jan 2008 | A1 |
20080027503 | Marrosu et al. | Jan 2008 | A1 |
20080027504 | Bedenbaugh | Jan 2008 | A1 |
20080027514 | Demulling et al. | Jan 2008 | A1 |
20080027540 | Cumming | Jan 2008 | A1 |
20080039895 | Fowler et al. | Feb 2008 | A1 |
20080046012 | Covalin et al. | Feb 2008 | A1 |
20080046013 | Lozano | Feb 2008 | A1 |
20080058630 | Robertson | Mar 2008 | A1 |
20080077186 | Thompson et al. | Mar 2008 | A1 |
20080077191 | Morrell | Mar 2008 | A1 |
20080103547 | Okun et al. | May 2008 | A1 |
20080103548 | Fowler et al. | May 2008 | A1 |
20080103578 | Gerber | May 2008 | A1 |
20080114417 | Leyde | May 2008 | A1 |
20080119900 | DiLorenzo | May 2008 | A1 |
20080139870 | Gliner et al. | Jun 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080154328 | Thompson et al. | Jun 2008 | A1 |
20080154331 | John et al. | Jun 2008 | A1 |
20080154340 | Goetz et al. | Jun 2008 | A1 |
20080161881 | Firlik et al. | Jul 2008 | A1 |
20080161896 | Sauter-Starace | Jul 2008 | A1 |
20080172103 | Kao et al. | Jul 2008 | A1 |
20080177196 | Burdick et al. | Jul 2008 | A1 |
20080188905 | Swartz | Aug 2008 | A1 |
20080195166 | Sun et al. | Aug 2008 | A1 |
20080195227 | Boling et al. | Aug 2008 | A1 |
20080208283 | Vetter et al. | Aug 2008 | A1 |
20080208287 | Palermo et al. | Aug 2008 | A1 |
20080215125 | Farah et al. | Sep 2008 | A1 |
20080221642 | Humayun et al. | Sep 2008 | A1 |
20080242976 | Robertson et al. | Oct 2008 | A1 |
20080255439 | Tang et al. | Oct 2008 | A1 |
20080255629 | Jenson et al. | Oct 2008 | A1 |
20080255647 | Jensen et al. | Oct 2008 | A1 |
20080269835 | Carlson et al. | Oct 2008 | A1 |
20080269842 | Giftakis et al. | Oct 2008 | A1 |
20080275526 | Lozano | Nov 2008 | A1 |
20080284599 | Zdeblick et al. | Nov 2008 | A1 |
20080294218 | Savage et al. | Nov 2008 | A1 |
20080300652 | Lim et al. | Dec 2008 | A1 |
20080306394 | Zdeblick et al. | Dec 2008 | A1 |
20080312726 | Frank et al. | Dec 2008 | A1 |
20080316020 | Robertson et al. | Dec 2008 | A1 |
20090027504 | Lim et al. | Jan 2009 | A1 |
20090062879 | Li et al. | Mar 2009 | A1 |
20090082645 | Hafezi et al. | Mar 2009 | A1 |
20090105784 | Massoud-Ansari et al. | Apr 2009 | A1 |
20090118806 | Vetter et al. | May 2009 | A1 |
20090132042 | Hetke et al. | May 2009 | A1 |
20090171416 | Firlik et al. | Jul 2009 | A1 |
20090177144 | Masmanidis et al. | Jul 2009 | A1 |
20090187196 | Vetter | Jul 2009 | A1 |
20090204183 | Kreidler et al. | Aug 2009 | A1 |
20090240314 | Kong et al. | Sep 2009 | A1 |
20090253977 | Kipke et al. | Oct 2009 | A1 |
20090256702 | Robertson et al. | Oct 2009 | A1 |
20090292325 | Cederna et al. | Nov 2009 | A1 |
20090299174 | Wright et al. | Dec 2009 | A1 |
20090306728 | Wright et al. | Dec 2009 | A1 |
20090306729 | Doerr | Dec 2009 | A1 |
20090312770 | Kozai et al. | Dec 2009 | A1 |
20090318824 | Nishida et al. | Dec 2009 | A1 |
20090325424 | Aarts et al. | Dec 2009 | A1 |
20100014541 | Harriman | Jan 2010 | A1 |
20100015274 | Fill | Jan 2010 | A1 |
20100030298 | Martens et al. | Feb 2010 | A1 |
20100036468 | Decre et al. | Feb 2010 | A1 |
20100047376 | Imbeau et al. | Feb 2010 | A1 |
20100069717 | Hafezi et al. | Mar 2010 | A1 |
20100076536 | Merz et al. | Mar 2010 | A1 |
20100087853 | Kipke et al. | Apr 2010 | A1 |
20100100152 | Martens et al. | Apr 2010 | A1 |
20100106178 | Obermiller et al. | Apr 2010 | A1 |
20100114193 | Lozano et al. | May 2010 | A1 |
20100114234 | Zdeblick | May 2010 | A1 |
20100114250 | Zdeblick | May 2010 | A1 |
20100130844 | Williams et al. | May 2010 | A1 |
20100145216 | He et al. | Jun 2010 | A1 |
20100145414 | Decre et al. | Jun 2010 | A1 |
20100152747 | Padiy et al. | Jun 2010 | A1 |
20100198315 | Martens et al. | Aug 2010 | A1 |
20100249883 | Zdeblick | Sep 2010 | A1 |
20100274305 | Gliner et al. | Oct 2010 | A1 |
20100292602 | Worrell et al. | Nov 2010 | A1 |
20100298908 | Vardiman | Nov 2010 | A1 |
20100298917 | Vardiman | Nov 2010 | A1 |
20100298918 | Vardiman | Nov 2010 | A1 |
20100312188 | Robertson et al. | Dec 2010 | A1 |
20100312228 | Zdeblick et al. | Dec 2010 | A1 |
20100318163 | Zdeblick | Dec 2010 | A1 |
20100331807 | Whitehurst et al. | Dec 2010 | A1 |
20110001488 | Behzadi et al. | Jan 2011 | A1 |
20110022124 | Zdeblick et al. | Jan 2011 | A1 |
20110034964 | Bi et al. | Feb 2011 | A1 |
20110034970 | Barker | Feb 2011 | A1 |
20110040203 | Savage et al. | Feb 2011 | A1 |
20110071766 | Dolan et al. | Mar 2011 | A1 |
20110130809 | Zdeblick | Jun 2011 | A1 |
20110152988 | Whitehurst et al. | Jun 2011 | A1 |
20110154655 | Hetke et al. | Jun 2011 | A1 |
20110184495 | Wang et al. | Jul 2011 | A1 |
20110190860 | Harberts et al. | Aug 2011 | A1 |
20110196454 | Strand et al. | Aug 2011 | A1 |
20110208225 | Martens et al. | Aug 2011 | A1 |
20110213382 | Decre et al. | Sep 2011 | A1 |
20110218417 | Boogaard et al. | Sep 2011 | A1 |
20110224757 | Zdeblick et al. | Sep 2011 | A1 |
20110224765 | Harberts et al. | Sep 2011 | A1 |
20110224766 | Tol et al. | Sep 2011 | A1 |
20110282179 | Zdeblick | Nov 2011 | A1 |
20120004520 | Whitworth et al. | Jan 2012 | A1 |
20120004527 | Thompson et al. | Jan 2012 | A1 |
20120004716 | Langhammer et al. | Jan 2012 | A1 |
20120007734 | Berkman et al. | Jan 2012 | A1 |
20120022341 | Zdeblick | Jan 2012 | A1 |
20120035684 | Thompson et al. | Feb 2012 | A1 |
20120053344 | Lagos Gonzalez | Mar 2012 | A1 |
20120059444 | Pardoel et al. | Mar 2012 | A1 |
20120062379 | Hafezi et al. | Mar 2012 | A1 |
20120095355 | Zdeblick | Apr 2012 | A1 |
20120109262 | Martens | May 2012 | A1 |
20120109599 | Martens | May 2012 | A1 |
20120116188 | Frank et al. | May 2012 | A1 |
20120136420 | Pardoel et al. | May 2012 | A1 |
20120150256 | Martens | Jun 2012 | A1 |
20120184837 | Martens et al. | Jul 2012 | A1 |
20120253442 | Gliner et al. | Oct 2012 | A1 |
20120277821 | Martens et al. | Nov 2012 | A1 |
20120296444 | Greenberg et al. | Nov 2012 | A1 |
20120302912 | Moffitt et al. | Nov 2012 | A1 |
20120303088 | Van Kaam et al. | Nov 2012 | A1 |
20120303089 | Martens et al. | Nov 2012 | A1 |
20120303107 | Decre et al. | Nov 2012 | A1 |
20120316630 | Firlik et al. | Dec 2012 | A1 |
20130009691 | Blanken et al. | Jan 2013 | A1 |
20130030366 | Robertson et al. | Jan 2013 | A1 |
20130046356 | Jensen et al. | Feb 2013 | A1 |
20130060102 | Zdeblick | Mar 2013 | A1 |
20130085361 | Mercanzini | Apr 2013 | A1 |
20130131754 | Sarvazyan | May 2013 | A1 |
20130144132 | Hafezi et al. | Jun 2013 | A1 |
20130172716 | Lozano et al. | Jul 2013 | A1 |
20130193950 | Hafezi et al. | Aug 2013 | A1 |
20130204318 | Young | Aug 2013 | A1 |
20130223028 | Arne et al. | Aug 2013 | A1 |
20130231188 | Berberich et al. | Sep 2013 | A1 |
20130282090 | Decre et al. | Oct 2013 | A1 |
20130345780 | Tabada et al. | Dec 2013 | A1 |
20130345789 | Havel et al. | Dec 2013 | A1 |
20140039578 | Whitehurst et al. | Feb 2014 | A1 |
20140066999 | Carcieri et al. | Mar 2014 | A1 |
20140200633 | Moffitt | Jul 2014 | A1 |
20140277284 | Chen et al. | Sep 2014 | A1 |
20150051678 | Reed et al. | Feb 2015 | A1 |
20150105774 | Lindquist et al. | Apr 2015 | A1 |
20150142090 | Duijsens et al. | May 2015 | A1 |
20150151111 | Pianca et al. | Jun 2015 | A1 |
20150209578 | Kast et al. | Jul 2015 | A1 |
20150246233 | Kaemmerer | Sep 2015 | A1 |
20150290452 | Kokones et al. | Oct 2015 | A1 |
20150335258 | Masmanidis | Nov 2015 | A1 |
20150355413 | Bhagavatula | Dec 2015 | A1 |
20150360023 | Howard et al. | Dec 2015 | A1 |
20160008592 | Romero et al. | Jan 2016 | A1 |
20160023003 | Perryman et al. | Jan 2016 | A1 |
20160074651 | Moffitt et al. | Mar 2016 | A1 |
20160144186 | Kaemmerer et al. | May 2016 | A1 |
20160228706 | Hershey et al. | Aug 2016 | A1 |
20160331953 | Reed et al. | Nov 2016 | A1 |
20160331975 | Henry et al. | Nov 2016 | A1 |
20160361535 | Perryman et al. | Dec 2016 | A1 |
20170007813 | Negi et al. | Jan 2017 | A1 |
20170049345 | Single | Feb 2017 | A1 |
20170136238 | Hartig et al. | May 2017 | A1 |
20170143982 | Mercanzini | May 2017 | A1 |
20170189700 | Moffitt et al. | Jul 2017 | A1 |
20170197086 | Howard et al. | Jul 2017 | A1 |
20170266432 | Seeley et al. | Sep 2017 | A1 |
20170296808 | Greenberg et al. | Oct 2017 | A1 |
20170361101 | Single | Dec 2017 | A1 |
20180185656 | Shepard et al. | Jul 2018 | A1 |
Number | Date | Country |
---|---|---|
101027085 | Aug 2007 | CN |
101600470 | Dec 2009 | CN |
201871104 | Jun 2011 | CN |
102274074 | Dec 2011 | CN |
102341036 | Feb 2012 | CN |
0 586 664 | Mar 1994 | EP |
0 677 743 | Oct 1995 | EP |
0 743 839 | Nov 1996 | EP |
0 892 654 | Jan 1999 | EP |
0 895 483 | Feb 1999 | EP |
0 959 942 | Dec 1999 | EP |
1 048 319 | Nov 2000 | EP |
1 062 973 | Dec 2000 | EP |
1 102 607 | May 2001 | EP |
1 257 320 | Nov 2002 | EP |
1 446 189 | Aug 2004 | EP |
1 514 576 | Mar 2005 | EP |
1 750 798 | Feb 2007 | EP |
1 890 764 | Feb 2008 | EP |
1 931 419 | Jun 2008 | EP |
1 985 579 | Oct 2008 | EP |
1 993 665 | Nov 2008 | EP |
2 046 441 | Apr 2009 | EP |
2 066 396 | Jun 2009 | EP |
2 069 003 | Jun 2009 | EP |
2 131 916 | Dec 2009 | EP |
2 144 665 | Jan 2010 | EP |
2 167 188 | Mar 2010 | EP |
2 320 221 | May 2011 | EP |
2 341 979 | Jul 2011 | EP |
2 389 975 | Nov 2011 | EP |
2 456 513 | May 2012 | EP |
2 476 453 | Jul 2012 | EP |
2 542 303 | Jan 2013 | EP |
2 559 454 | Feb 2013 | EP |
2 604 313 | Jun 2013 | EP |
2 618 889 | Jul 2013 | EP |
2 620 179 | Jul 2013 | EP |
2 623 154 | Aug 2013 | EP |
2 626 108 | Aug 2013 | EP |
2 626 109 | Aug 2013 | EP |
2 626 110 | Aug 2013 | EP |
2 626 111 | Aug 2013 | EP |
2 656 875 | Oct 2013 | EP |
2 656 876 | Oct 2013 | EP |
2 664 354 | Nov 2013 | EP |
2 674 193 | Dec 2013 | EP |
2 862 595 | Apr 2015 | EP |
3 111 835 | Jan 2017 | EP |
3 231 476 | Oct 2017 | EP |
2005-052647 | Mar 2005 | JP |
2012-179333 | Sep 2012 | JP |
WO-9810010 | Mar 1998 | WO |
WO-03022354 | Mar 2003 | WO |
WO-03028521 | Apr 2003 | WO |
WO-03066152 | Aug 2003 | WO |
WO-03066153 | Aug 2003 | WO |
WO-03066157 | Aug 2003 | WO |
WO-2004043536 | May 2004 | WO |
WO-2018068013 | May 2004 | WO |
WO-2004045707 | Jun 2004 | WO |
WO-2005002467 | Jan 2005 | WO |
WO-2005067792 | Jul 2005 | WO |
WO-2005112216 | Nov 2005 | WO |
WO-2006104432 | Oct 2006 | WO |
WO-2007002144 | Jan 2007 | WO |
WO-2007009070 | Jan 2007 | WO |
WO-2007011611 | Jan 2007 | WO |
WO-2007025356 | Mar 2007 | WO |
WO-2007028003 | Mar 2007 | WO |
WO-2007042999 | Apr 2007 | WO |
WO-2007092330 | Aug 2007 | WO |
WO-2007100428 | Sep 2007 | WO |
WO-2007108718 | Sep 2007 | WO |
WO-2008003318 | Jan 2008 | WO |
WO-2008005478 | Jan 2008 | WO |
WO-2008016881 | Feb 2008 | WO |
WO-2008035285 | Mar 2008 | WO |
WO-2008035344 | Mar 2008 | WO |
WO-2008051463 | May 2008 | WO |
WO-2008064269 | May 2008 | WO |
WO-2008068759 | Jun 2008 | WO |
WO-2008075294 | Jun 2008 | WO |
WO-2008077440 | Jul 2008 | WO |
WO-2008088897 | Jul 2008 | WO |
WO-2008089726 | Jul 2008 | WO |
WO-2008107822 | Sep 2008 | WO |
WO-2008109298 | Sep 2008 | WO |
WO-2008133616 | Nov 2008 | WO |
WO-2008133683 | Nov 2008 | WO |
WO-2008138305 | Nov 2008 | WO |
WO-2010014686 | Feb 2010 | WO |
WO-2010055421 | May 2010 | WO |
WO-2011000791 | Jan 2011 | WO |
WO-2011115999 | Sep 2011 | WO |
WO-2013014206 | Jan 2013 | WO |
Entry |
---|
US 8,388,533 B2, 03/2013, Hafezi et al. (withdrawn) |
US 8,469,885 B2, 06/2013, Hafezi et al. (withdrawn) |
Extended European Search Report for EP Application No. 18208814.6 dated Mar. 28, 2019. |
Final Office Action on U.S. Appl. No. 15/369,766 dated Feb. 7, 2019 |
International Preliminary Report on Patentability and Written Opinion for PCT/IB2017/050551 dated Aug. 16, 2018. |
Notice of Allowance on U.S. Appl. No. 14/731,296 dated Aug. 15, 2018. |
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Nov. 9, 2018. |
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jun. 1, 2018. |
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Oct. 3, 2018. |
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Dec. 5, 2018. |
Office Action for CA Application No. 2,795,159 dated Dec. 18, 2018. |
Office Action for Chinese Application No. 201580016170.1 dated Jan. 28, 2019. |
Notice of Allowance for U.S. Appl. No. 15/369,766 dated Oct. 17, 2019 (12 pages). |
Bucher et al., “Low-impedance thin-film polycrystalline silicon microelectrodes for extracellular stimulation and recording”, Biosensors & Bioelectronics, vol. 14, 1999, pp. 639-649 (11 pages). |
European Search Report on EP 16190439 dated Jul. 19, 2017 (2 pages). |
Extended European Search Report on EP 19165102.5 dated Jul. 8, 2019 (7 pages). |
Final Office Action on U.S. Appl. No. 16/015,625 dated Dec. 28, 2018 (13 pages). |
Hosp et al., “Thin-film epidural microelectrode arrays for somatosensory and motor cortex mapping in rat”, Journal of Neuroscience Methods, vol. 172, 2008, pp. 255-262 (8 pages). |
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/051635 dated Jun. 3, 2019 (13 pages). |
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/053275 dated Jul. 4, 2019 (12 pages). |
Janders et al., “Novel Thin Film Titanium Nitride Micro-Electrodes With Excellent Charge Transfer Capability for Cell Stimulation and Sensing Applications”, 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1996, Amsterdam (3 pages). |
Moxon et al., “Nanostructured Surface Modification of Ceramic-Based Microelectrodes to Enhance Biocompatibility for a Direct Brain-Machine Interface”, IEEE Transactions on Biomedical Engineering, vol. 51, No. 6, Jun. 2004, pp. 881-889 (9 pages). |
Non-Final Office Action on U.S. Appl. No. 15/369,766 dated May 31, 2019 (10 pages). |
Non-Final Office Action on U.S. Appl. No. 16/015,625 dated Aug. 9, 2018 (14 pages). |
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Jun. 10, 2019 (2 pages). |
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Apr. 26, 2019 (5 pages). |
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jul. 27, 2018 (2 pages). |
Notice of Allowance on U.S. Appl. No. 16/015,625 dated Mar. 28, 2019 (8 pages). |
Notice of Allowance on U.S. Appl. No. 16/015,625 dated May 8, 2019 (8 pages). |
Notice of Reasons for Rejection on JP 2017-530450 dated Jul. 11, 2019 (4 pages). |
Office Action on CN 201580016170.1 dated Jan. 28, 2019 (10 pages). |
Ziaie et al., “A Single-Channel Implantable Microstimulator for Functional Neuromuscular Stimulation”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 10, Oct. 1997, pp. 909-920 (12 pages). |
Cogan, S., et al. “Plasma-enhanced chemical vapor deposited silicon carbide as an implantable dielectric coating.” Journal of Biomedical Materials Research Part A 67.3 (2003): 856-867. |
Communication from the European Patent Office in Application No. 09795810.2 dated Sep. 14, 2011. |
EIC Biomedical, “Thin-film Encapsulation for Neural Recording and Stimulation Electrodes”, Silicon carbide and oxycarbide, Apr. 2008: pp. 1-2. |
European Search Report for Appl. Serial No. 09803534.8 dated Jul. 21, 2011. |
Fierce Medical Devices, “Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker”, Feb. 20, 2014, pp. 1-3. |
Gibney, “St. Jude places its Nanostim leadless pacemaker in a U.K. patient”, Fierce Medical Devices, Jan. 27, 2014, pp. 1-3. |
International Search Report and Written Opinion in PCT/US09/52077 dated Sep. 25, 2009. |
International Search Report for PCT/IB2009/007715 dated Apr. 22, 2010. |
Written Opinion of the International Search Authority for PCT/IB2009/07715 dated May 12, 2011. |
Extended European Search Report for EP 19174013.3 dated Oct. 8, 2019 (7 pages). |
U.S. Appl. No. 07/151,961, filed Feb. 3, 1988, Masahiko Okunuki et al. |
U.S. Appl. No. 07/184,829, filed Apr. 22, 1988, Tsutsui et al. |
Australian Patent Examination Report No. 1 dated Jan. 30, 2014 in corresponding Australian Application No. 2010326613, 2 pages. |
Australian Patent Examination Report No. 1 dated Jan. 31, 2014 in corresponding Australian Application No. 2009315316, 3 pages. |
Benabid, et al. “Combined (Thalamotomy and Stimulation) Stereotactic Surgery of the VIM Thalamic Nucleus for Bilateral Parkinson Disease”, Proceedings of the Meeting of the American Society for Stereotactic and Functional Neurosurgery, Montreal 1987 Appl. Neurophysiol. 50: 344-346. |
Canadian Office Action for Application No. 2,743,575 dated Sep. 25, 2014, 3 pages. |
Decision of Rejection and Decision for Dismissal of Amendment in JP Patent Application No. 2011-543841 dated May 15, 2014. |
Decision of Rejection for Japanese Appl. Ser. No. 2012-541491 dated Oct. 26, 2015. |
English translation of Notice of Reasons for Rejection in JP application No. 2011-543841 dated Oct. 21, 2013. |
European Communication and Search Report for Application No. 09795810.2 dated Sep. 25, 2013. |
European Communication dated May 22, 2013 including search report for EP application No. 12198290.4-1652. |
European Search Report for Appl. Ser. No. 09803534.8 dated Jul. 21, 2011. |
European Search Report for Appl. Ser. No. 13169272.5 dated Aug. 30, 2013. |
European Search Report for application No. EP 14172592 dated Aug. 28, 2014, 8 pages. |
Examination Report for EP09795810.2 dated Jun. 22, 2012. |
Examination Report from European Patent Office in 09 795 810.2 dated May 8, 2014. |
Examination Report in AU Patent Application No. 2009276603 dated Mar. 3, 2014. |
Examination report in AU Patent Application No. 2011234422 dated Feb. 11, 2014. |
Examination Report in EP Patent Application No. 11 711 884.4 dated Mar. 28, 2014. |
International Preliminary Report on Patentability for PCT/EP2010/068658 dated Jun. 5, 2012. |
International Preliminary Report on Patentability for PCT/IB2009/007715 dated May 17, 2011. |
International Preliminary Report on Patentability for PCT/US2009/052077 dated Feb. 1, 2011. |
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/053610 dated Jul. 20, 2015. |
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/056437 dated Nov. 5, 2015. |
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/056438 dated Nov. 5, 2015. |
International Search Report and Written Opinion for PCT/EP2010/068658 dated Mar. 21, 2011. |
International Search Report and Written Opinion in Application No. PCT/EP2011/055045 dated Jul. 18, 2011. |
Notice of Allowance for U.S. Appl. No. 14/287,917 dated Apr. 15, 2015. |
Notice of Allowance on U.S. Appl. No. 14/470,423 dated Jun. 15, 2016. |
Notice of Allowance on U.S. Appl. No. 15/194,033 dated Oct. 27, 2016. |
Notice of Reasons for Rejection for Japanese Patent Application No. 2011-543841 dated May 30, 2013. |
Notice of Reasons for Rejection in JP Patent Application No. 2011-521276 dated Mar. 3, 2014. |
Notice of Reasons for Rejection in JP Patent Application No. 2011-521276 dated May 30, 2013. |
Notice of Reasons for Rejections for Japanese Patent Appl. Serial No. 2012-541491 dated Aug. 28, 2014, 8 pages. |
Office Action for Canadian Appl. Ser. No. 2732309 dated Dec. 7, 2015. |
Office Action for Canadian Appl. Ser. No. 2743575 dated Jan. 21, 2015 (4 pages). |
Office Action for Canadian Appl. Ser. No. 2743575 dated Jun. 11, 2015. |
Office Action for Canadian Appl. Ser. No. 2743575 dated Sep. 14, 2015. |
Office Action for EPO Appl. Ser. No. 10787404.2 dated May 6, 2015. |
Office Action for EPO Appl. Ser. No. 14172592.9 dated Aug. 20, 2015. |
Office Action for European Application No. 10787404.2 dated Mar. 26, 2013. |
Office Action for Japanese Appl. Ser. No. 2013-501857 dated Jun. 1, 2015. |
Office Action for Japanese Appl. Ser. No. 2013-501857 dated Sep. 17, 2014. |
Office Action on U.S. Appl. No. 14/731,296 dated Oct. 5, 2016. |
Office Action on U.S. Appl. No. 14/945,952 dated Jul. 26, 2016. |
Office Action on U.S. Appl. No. 15/194,033 dated Aug. 22, 2016. |
Pollak, et al. “Effets de la Stimulation du Noyau Sous-Thalamique Dans La Maladie De Parkinson”, Rev. Neurol (Paris),149, 3, 175-176. Mason, Paris, 1993. |
Rousche, et al., “Flexible polyimide-based intracortical electrode arrays with bioactive capability,” IEEE Transactions on Biomedical Engineering 48(3): 361-371 (Mar. 2001). |
Second Notice of Reasons for Rejection for Japanese Application No. 2012-541491 dated Apr. 8, 2015. |
Sepulveda et al., “Finite Element Analysis of Current Pathways with Implanted Electrodes”, J. Biomed. Eng. 1983, vol. 5, pp. 41-48. |
U.S. Corrected Notice of Allowability for U.S. Appl. No. 14/470,356 dated May 18, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/287,917 dated Jul. 20, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 14/309,491 dated May 11, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/316,154 dated Apr. 20, 2015. |
U.S. Notice of Allowance for U.S. Appl. No. 14/470,356 dated Apr. 13, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 14/470,356 dated Mar. 18, 2016. |
U.S. Notice of Allowance for U.S. Appl. No. 13/512,936 dated Feb. 20, 2014. |
U.S. Notice of Allowance for U.S. Appl. No. 13/512,936 dated Nov. 25, 2013. |
U.S. Notice of Allowance for U.S. Appl. No. 13/056,261 dated May 8, 2014. |
U.S. Notice of Allowance in U.S. Appl. No. 13/128,821 dated Dec. 24, 2013. |
U.S. Notice of Allowance in U.S. Appl. No. 13/128,821 dated Mar. 25, 2014. |
U.S. Notice of Allowance on U.S. Appl. No. 13/638,435 dated Sep. 16, 2016. |
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Nov. 14, 2013. |
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Feb. 10, 2016. |
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Jun. 30, 2015. |
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Mar. 12, 2015. |
U.S. Office Action for U.S. Appl. No. 14/309,491 dated Jul. 28, 2015. |
U.S. Office Action for U.S. Appl. No. 14/309,491 dated Mar. 3, 2016. |
U.S. Office Action for U.S. Appl. No. 14/470,423 dated Jan. 21, 2016. |
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Dec. 14, 2012. |
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Apr. 24, 2012. |
U.S. Office Action for U.S. Appl. No. 14/316,154 dated Dec. 18, 2014. |
U.S. Office Action for U.S. Appl. No. 13/512,936 dated Aug. 14, 2013. |
U.S. Office Action for U.S. Appl. No. 13/056,261 dated Jan. 9, 2014. |
U.S. Office Action in U.S. Appl. No. 13/056,261 dated Aug. 7, 2013. |
U.S. Office Action on U.S. Appl. No. 14/287,917 dated Sep. 26, 2014. |
Written Opinion for PCT/EP2010/068658 dated Jun. 1, 2012. |
Written Opinion for Singapore Application No. 201103393-3 dated May 2, 2012. |
Canadian Office Action for CA 2,732,309 dated Nov. 8, 2016. |
U.S. Notice of Allowance on U.S. Appl. No. 14/945,952 dated Dec. 7, 2016. |
Non-Final Office Action for U.S. Appl. No. 15/910,278 dated Nov. 26, 2019 (7 pages). |
First Office Action for CN 201580019701.2 dated Nov. 15, 2019 (18 pages). |
Office Action for CA 3026948 dated Jan. 15, 2020 (4 pages). |
Non-Final Office Action on U.S. Appl. No. 15/962,632 dated Mar. 30, 2020 (10 pages). |
Non-Final Office Action on U.S. Appl. No. 16/236,716 dated Apr. 29, 2020 (9 pages). |
Notice of Allowance on U.S. Appl. No. 15/369766 dated Mar. 5, 2020 (8 pages). |
Notice of Allowance on U.S. Appl. No. 15/910278 dated Mar. 9, 2020 (8 pages). |
Chinese Office Action on CN 201580019701.2 dated Aug. 17, 2020 (9 pages) |
Final Office Action on U.S. Appl. No. 15/962,632 dated Oct. 6, 2020 (13 pages). |
International Preliminary Report on Patentability on PCT/IB2019/051635 dated Sep. 17, 2020 (7 pages). |
International Preliminary Report on Patentability on PCT/IB2019/053275 dated Nov. 5, 2020 (8 pages). |
Number | Date | Country | |
---|---|---|---|
20170105641 A1 | Apr 2017 | US |
Number | Date | Country | |
---|---|---|---|
61994359 | May 2014 | US |